OKAngel Sidecar Fund Invests in Altheus Therapeutics

The SeedStep Angels and the OKAngel Sidecar Fund, managed by i2E have closed a $400,000 investment in Oklahoma City-based Altheus Therapeutics, a company that has developed a combination therapy for ulcerative colitis. The investment was a second closing of a Series B financing round, the first of which included the Oklahoma Seed Capital Fund, which totaled $3.0 million.

9 October 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail